Longeveron News

HC Wainwright & Co. : The Longeveron (LGVN.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $6.00 to $12.00.

Zhitong FinanceApr 30 00:40

Longeveron Analyst Ratings

BenzingaApr 30 00:36

HC Wainwright & Co. Maintains Buy on Longeveron, Adjusts Price Target To $12

BenzingaApr 30 00:39

Analysts' Top Healthcare Picks: Longeveron (LGVN), Optinose (OPTN)

TipRanksApr 29 18:20

Longeveron (LGVN) Receives a Buy From Maxim Group

TipRanksMar 2 04:25

Buy Rating Affirmed: Longeveron's Intellectual Property and Pipeline Progress Signal Market Growth

TipRanksJan 30 19:15

Buy Rating Affirmed for Longeveron on Promising CLEAR MIND Trial Results and Strong Lomecel-B Potential

TipRanksJan 5 19:31

HC Wainwright Initiates Longeveron With Buy Rating, Price Target Is $6

MT NewswiresDec 4, 2023 21:01

Longeveron Analyst Ratings

BenzingaDec 4, 2023 19:42

Longeveron's Lomecel-B: A Dual-Therapeutic Prospect Transforming Treatment in HLHS and AD With a Strong Buy Rating

TipRanksDec 4, 2023 19:18

Maxim Group Reaffirms Their Buy Rating on Longeveron (LGVN)

TipRanksAug 13, 2023 03:15

EF Hutton Assumes Longeveron at Buy, Announces Price Target of $12.5

BenzingaJun 1, 2023 16:48

Longeveron (LGVN) Gets a Buy From Maxim Group

TipRanksMay 11, 2023 02:35

Longeveron (LGVN) Gets a Buy From EF Hutton

TipRanksMay 10, 2023 04:32

EF Hutton Reiterates Buy on Longeveron, Maintains $12.5 Price Target

BenzingaMay 10, 2023 00:50

Maxim Group Remains a Buy on Longeveron (LGVN)

TipRanksApr 20, 2023 23:42

EF Hutton Reiterates Buy on Longeveron, Maintains $12.5 Price Target

BenzingaMar 27, 2023 21:40

Maxim Group Sticks to Its Buy Rating for Longeveron (LGVN)

TipRanksMar 12, 2023 00:26

Maxim Group Sticks to Its Buy Rating for Longeveron (LGVN)

TipRanksJan 14, 2023 02:00

EF Hutton Adjusts Longeveron Price Target to $12.50 From $20, Maintains Buy Rating

MT NewswiresJan 10, 2023 20:53